Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
44
LNMG Quote, Financials, Valuation and Earnings
Last price:
$0.0200
Seasonality move
:
50.26%
Day range:
$0.0188 - $0.0197
52-week range:
$0.0028 - $1.5000
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
11K
Avg. volume:
30K
1-year change:
-91.83%
Market cap:
$65.3K
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Linike Medical Group has 183788.46% upside to fair value with a price target of -- per share.
LNMG vs. S&P 500
-
Over the past 5 trading days, Linike Medical Group has underperformed the S&P 500 by -6.06% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Linike Medical Group does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Linike Medical Group has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Linike Medical Group reported revenues of --.
Earnings Growth
-
Linike Medical Group has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Linike Medical Group reported earnings per share of --.
Enterprise value:
66.5K
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.35x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2012-07-31 | 2013-07-31 | 2014-07-31 | 2013-07-31 | 2014-07-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | $12.1K | -$14.6K | -- | -- | -- | |
| Operating Income | -$108.1K | -$160K | -$303.9K | -$60.2K | -$11.2K | |
| EBITDA | -$106.5K | -$159.4K | -$303.9K | -$60.1K | -$11.2K | |
| Diluted EPS | -$0.01 | -$0.00 | -$0.00 | -$0.00 | -- | |
| Period Ending | 2010-07-31 | 2011-07-31 | 2012-07-31 | 2013-07-31 | 2014-07-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $23.1K | $55K | $150 | |
| Total Assets | -- | -- | $25.4K | $220.2K | $150 | |
| Current Liabilities | -- | -- | $16.1K | $466.6K | $531.7K | |
| Total Liabilities | -- | -- | $16.1K | $466.6K | $531.7K | |
| Total Equity | -- | -- | $9.4K | -$246.4K | -$531.6K | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2012-07-31 | 2013-07-31 | 2014-07-31 | 2013-07-31 | 2014-07-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$9.7K | $137.1K | -$188.9K | -$11.9K | $3K | |
| Cash From Investing | -- | -$165.1K | $165.1K | -- | -- | |
| Cash From Financing | -- | $18.2K | -- | -- | -- | |
| Free Cash Flow | -$9.7K | $137.1K | -$188.9K | -$11.9K | $3K | |
LNMG
Sector
Market Cap
$65.3K
--
Price % of 52-Week High
1.25%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
-91.83%
--
Beta (5-Year)
--
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.0206
200-day SMA
Sell
Level
$0.1726
Bollinger Bands (100)
Buy
Level
-0.0041 - 0.0359
Chaikin Money Flow
Sell
Level
-82.3K
20-day SMA
Buy
Level
$0.0117
Relative Strength Index (RSI14)
Buy
Level
59.3335
ADX Line
Buy
Level
30.5749
Williams %R
Neutral
Level
-65.5
50-day SMA
Buy
Level
$0.0084
MACD (12, 26)
Buy
Level
0.0065
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
465.7K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (1)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Linike Medical Group Ltd along with its subsidiaries specializes in the R&D, production, and sales of large-scale external beam therapy equipment-medical electron linear accelerator, used for treating cancers.
Stock Forecast FAQ
In the current month, LNMG has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LNMG average analyst price target in the past 3 months is --.
-
Where Will Linike Medical Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that Linike Medical Group share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Linike Medical Group?
Analysts are divided on their view about Linike Medical Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Linike Medical Group is a Sell and believe this share price will drop from its current level to --.
-
What Is Linike Medical Group's Price Target?
The price target for Linike Medical Group over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is LNMG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Linike Medical Group is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of LNMG?
You can purchase shares of Linike Medical Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Linike Medical Group shares.
-
What Is The Linike Medical Group Share Price Today?
Linike Medical Group was last trading at $0.0200 per share. This represents the most recent stock quote for Linike Medical Group. Yesterday, Linike Medical Group closed at $0.0188 per share.
-
How To Buy Linike Medical Group Stock Online?
In order to purchase Linike Medical Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
